Immune Targeting of Senescence Cells for the Treatment of Fibrotic Lung Disease
Time: 9:30 am
day: Day Two
Details:
- Discuss the role of invariant Natural Killer T cells (iNKTs) in the modulation of cellular senescence
- Examine the development of a novel glycolipid antigen that potently activates endogenous iNKTs with potent single-dose efficacy in the bleomycin-mediated murine model of IPF
- Explore the potential for iNKT-based therapeutics across different fibrotic diseases
